Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Qualified from the University of Leicester in 1991. He trained in Leicester, Southampton and Portsmouth and was involved in the early development of EVAR within the UK, work that led to his MD thesis. He undertook a year of endovascular training at the Royal Adelaide Hospital prior to his appointment as Consultant Vascular Surgeon at Addenbrooke’s Hospital, Cambridge in 2002.
He has active research interests in EVAR, outcome modelling and renal injury in vascular surgery, publishing extensively on these topics. He established an endovascular service for ruptured aneurysms in Cambridge.
He is the current President of the Vascular Society of Great Britain and Ireland (2021-2022) and served as British Society of Endovascular Therapy President from 2013-2015. He is Senior Editor elect of European Journal of Vascular and Endovascular Surgery and also a long-standing member of the Editorial Board of the Journal of Endovascular Therapy.
Furthermore he is enthusiastic about post-graduate training, he served as Training Programme Director for Core Surgical Training in the East of England from 2007-2012 and Chairman of the Vascular Specialty Advisory Committee (SAC) overseeing vascular training in the UK and Ireland from 2015-2018. He is an Affiliate Associate Professor in the Department of Surgery at the University of Cambridge.
He is the immediate past Chair of the Audit and QI Committee of the Vascular Society and was the driving force behind the Peripheral Arterial Disease Quality Improvement Framework (PAD-QIF) and collection of aortic device data within the National Vascular Registry. This work has led to his recent appointment as Chair of the Vascular Surgery and Interventional Radiology Steering Group for the NHS Medical Devices Safety Programme.
Professor Andrew Bradbury took up post as the Sampson Gamgee Professor of Vascular Surgery at the University of Birmingham (UoB), and as an Honorary Consultant Vascular Surgeon at the Heart of England (now University Hospitals Birmingham) NHS Foundation Trust, in January 2000, having previously worked as a Senior Lecturer and Consultant Surgeon at the University of Edinburgh since 1995, following training in General and Vascular Surgery in Scotland and London.
From 2005 to 2010, Andrew was the Education Dean responsible for running the MB ChB and all the other clinical programmes within the College of Medical and Dental Sciences at UoB. During that period, Andrew completed an MBA at the Birmingham Business School at UoB.
Between 2015 and 2022, Andrew was Chair of the UK National Institute of Health Research (NIHR) Health Technology Assessment (HTA) research programme Hospital-based Care Committee, and was also a member of the NIHR HTA Programme Oversight Committee, reporting to the Director.
Andrew co-authored the UK National Institute for Health and Care Excellence (NICE) national guidelines on Peripheral Arterial Disease (PAD) (2012) and on Varicose Veins and Leg Ulcers (2013), and also chaired the NICE Abdominal Aortic Aneurysm (AAA) national Guideline Committee (GC) (2015-2020).
Andrew has published over 250 articles in peer review journals and authored numerous book chapters. Recent publication highlights include the UK NIHR HTA funded EndoVenous Reflux Ablation (EVRA) trial results in the NEJM (2018), the Global Vascular Guidelines (GVG) on Chronic Limb Threatening Ischaemia (CLTI) in the JVS and EJVES (2019), and UK NIHR HTA funded Graduated compression stockings as an Adjuvant to Pharmaco-prophylaxis in elective Surgical patients (GAPS) trial in the BMJ (2020).
Andrew is Chief Investigator and grant-holder for the UK NIHR HTA funded BASIL-1, 2 and 3 trials. The BASIL-2 results were published in The Lancet in April 2023. Andrew expects to be able to publish the BASIL-3 results in a high impact journal towards the end of 2023.
Andrew retired from National Health Service (NHS) and private clinical practice at the end of 2022 but is still working part-time for the UoB in order to complete the BASIL-2 and -3 trials, and to see through various other academic commitments. Andrew has been awarded Emeritus Professor status by the UoB from the end of 2024.
Dr Dias is currently a Senior Consultant and Professor at the Vascular Center in Malmö and Lund University in Sweden. He defended his PhD thesis on endovascular aortic repair and direct intra-aneurysm pressure measurements in 2004. Dr Dias has published numerous peer reviewed articles and book chapters on vascular and endovascular surgery, particularly regarding aortic diseases. He is currently the head of the Endovascular Section at the Vascular Center in Malmö, a member of the Editorial Board of the European Journal of Vascular and Endovascular Surgery and of the Guidelines Committee, and the Scientific Secretary of the Swedish Vascular Society.
Dr Shalhub is the Division Head of Vascular & Endovascular Surgery at Oregon Health and Science University in Portland, Oregon, co-director of the Heart and Vascular service line, and Vice Chair for the Department of Surgery Regional Strategy and Surgical Operations. An expert in aortic & arterial dissections and aneurysms, Dr Shalhub’s research focuses on personalizing health care, improving the success of surgical repairs, and promoting quality of life for people living with these conditions. She is the lead investigator for the VEDS Collaborative Natural History Study and the PCORI-funded Aortic Dissection Collaborative.
Since 2020, PD Dr Austermann has been the head of department of the Clinic for Vascular Surgery at the St Franziskus Hospital Münster. The clinic treats more than 350 aortic pathologies per year and more than 2000 patients with all vascular pathologies per year. Endovascular treatment is one of the main focus areas of the clinic.
Before 2020, PD Dr Austermann was the senior consultant and leader of endovascular aortic repair for 10 years. Complex aortic repair with fenestrated and branched endografts was his main focus.
His scientific areas of focus are the studies of complex aortic repair and bench tests of covered stents using bridging stentgrafts or for occlusive vascular disease.
Brian G. DeRubertis, MD, FACS, is the Chief of the Division of Vascular & Endovascular Surgery at New York Presbyterian Hospital-Weill Cornell Medical School in New York City and is a Fellow of the American College of Surgeons. After obtaining his undergraduate degree at the University of California, Los Angeles, Dr. DeRubertis earned his medical degree, residency, and fellowship training at Weill Cornell Medical College and Columbia University training programs. He earned the rank of Professor of Surgery at the UCLA School of Medicine where he spent nearly 15 years with the Division of Vascular Surgery before returning to New York to rejoin Cornell’s Department of Surgery.
His clinical interests include open and endovascular management of complex aortic aneurysms, lower extremity arterial occlusive disease, carotid artery disease and deep venous disease.
Dr. DeRubertis has participated in more than 20 clinical research studies, including roles as National Principal Investigator in the REALITY Trial and the LIFE-BTK Trial. He has published more than 70 articles in peer-reviewed journals, and more than 25 book chapters and other publications. He has presented his own research and given invited presentations at regional, national and international academic conferences, including the SVS, NEVS, WVS, VERVE, VEITH, TCT, LINC, and VIVA, delivering over 300 presentations at these conferences.
Dr. DeRubertis has received several honors, and has been named among America’s Top Doctors by U.S. News and World Report in a collaboration with Castle Connolly Medical Ltd. that features peer-nominated physicians across 75 specialties.
Dr Resch completed his PhD on endovascular aortic repair in 1999 under guidance of Prof. Krassi Ivancev. He completed the Margret A. Smith fellowship in aortic surgery under the guidance of Dr. Roy Greenberg at the Cleveland Clinic 2004-2005. Dr Resch received a consultant position in Vascular Surgery at the Vascular Center in Malmö in 2005. He became Associate Professor of Vascular Surgery at Lund University in 2008 and served as the Chairman at the Vascular Center in Malmö 2013-2019. He is currently Professor of Vascular Surgery at Copenhagen University, the Lead of Complex Aortic Surgery at the Dept of Vascular Surgery and Copenhagen Aortic Center, Copenhagen, Denmark. Prof Resch has published >200 peer-reviewed articles and book chapters in the field of vascular surgery, been PI on several stent graft trials and is a frequently invited speaker at major international vascular meetings. He has performed and proctored >1000 complex aortic cases during his career and is currently on the organizing committee of Critical Issues on Aortic Endografting, Paris Endovascular Aortic Course and Paris Vascular Insights and a member of the ESVS Guidelines Steering Committee.
Nursing Program - Invited Speakers
Health Service Chief Executive – North West Hospital and Health Service
Sean brings over 39 years of nursing experience, including 20 years in senior leadership and management roles. In 2022 Sean worked as the Health Department COVID-19 System Response Lead coordinating the state's COVID-19 operational response.
Sean holds post graduate qualifications in Critical Care Nursing, Business Management and Masters in Health Management and spent seven years as an executive member of the Queensland Clinical Senate.
Sean has a keen interest in the development of staff into leadership roles and the promotion of new models of care. He also has a keen interest in disaster management and preparedness. Sean provides ongoing support to Indonesian nurses and health executives working in Bali as part of the Bali Memorial Package. This role incorporates assisting in the improvement of health services in Bali and developing the leadership and management skills of Balinese healthcare workers.
Sean is enjoying the challenges and opportunities of working in a remote environment, working with First Nations Communities within North West HHS.
Dr Harry Gibbs is a graduate of the University of Sydney. He trained in Cardiology and Vascular Medicine at St. Vincent's Hospital, Sydney, with subsequent training at The Cornell University Medical Center, New York. He has been the Director of the Department of Vascular Medicine at the Princess Alexandra Hospital in Brisbane, the Director of Cardiology at Lismore Base Hospital and is currently the Director of General Medicine at the Alfred Hospital, Melbourne, Australia. He is an Associate Professor of Medicine at Monash University. His interests are cardiovascular and general medicine, with a particular interest in thrombosis and anticoagulant therapy.
Jo is a hospital and university-trained registered nurse and trained counsellor, with a background in nursing, sales, training, and research.
Jo is the founder and director of Treat Healthcare. She is passionate about helping staff improve health and vitality, incorporating evidence-based modalities drawn from psychology, mindfulness, neuroscience and stress reduction interventions.
She currently runs ‘Treat’ programs and sessions to support staff in many workplaces. These include Alfred Health, Royal Melbourne Hospital, Royal Women’s Hospital, Beyond Blue, and Safer Care Victoria